Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of LT Patch for Travelers' Diarrhea
NCT01067781Phase 2Completed
- Sponsor
- Intercell AG
- Start
- Feb 2010
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of travellers' diarrhoea vaccine patch in traveler's diarrhea (TD) (4 arms), sponsored by Intercell AG. Primary endpoint: Characterization and Comparison of the Safety of the TD Vaccine System. Started Feb 2010; status: completed.
02
Drugs
travellers' diarrhoea vaccine patch
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT01067781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067781.